We are live on ! Find out more
OIMU

Osmosis Investment Management UK Portfolio holdings

AUM $2.15B
This Fund
S&P 500
This Quarter Est. Return
-3%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.72B
AUM Growth
-$243M
Cap. Flow
+$7.17M
Cap. Flow %
0.19%
Top 10 Hldgs %
33.86%
Holding
499
New
131
Increased
145
Reduced
180
Closed
43

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$38.4M
2
ADI icon
Analog Devices
ADI
+$32.8M
3
MU icon
Micron Technology
MU
+$19.2M
4
SO icon
Southern Company
SO
+$18.7M
5
MDT icon
Medtronic
MDT
+$18M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$24.3M
2
NVDA icon
NVIDIA
NVDA
+$23.2M
3
AAPL icon
Apple
AAPL
+$21.2M
4
AVGO icon
Broadcom
AVGO
+$20.4M
5
LIN icon
Linde
LIN
+$17.9M

Sector Composition

Rank Sector Weight
1 Technology 32.67%
2 Financials 13.53%
3 Healthcare 11.84%
4 Communication Services 10.01%
5 Consumer Discretionary 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DXCM icon
376
DexCom
DXCM
$34B
$633K 0.02%
10,072
+1,095
+12% +$76.3K
PTC icon
377
PTC
PTC
$17B
$611K 0.02%
+4,288
New +$678K
CRDO icon
378
Credo Technology Group
CRDO
$44.2B
$600K 0.02%
+6,396
New +$778K
EXPD icon
379
Expeditors International
EXPD
$24.7B
$600K 0.02%
+4,190
New +$637K
IMO icon
380
Imperial Oil
IMO
$62.8B
$600K 0.02%
4,578
-326
-7% -$36.6K
ULTA icon
381
Ulta Beauty
ULTA
$21.9B
$590K 0.02%
+1,128
New +$717K
CSL icon
382
Carlisle Companies
CSL
$14.1B
$575K 0.02%
1,725
+560
+48% +$204K
DHR icon
383
Danaher
DHR
$152B
$570K 0.02%
+3,001
New +$639K
ICL icon
384
ICL Group
ICL
$7.31B
$569K 0.02%
+111,087
New +$594K
PODD icon
385
Insulet
PODD
$10.1B
$555K 0.01%
2,647
-485
-15% -$122K
FFIV icon
386
F5
FFIV
$22.6B
$543K 0.01%
+1,876
New +$520K
LOW icon
387
Lowe's Companies
LOW
$116B
$537K 0.01%
+2,273
New +$593K
MGA icon
388
Magna International
MGA
$17.6B
$536K 0.01%
9,628
+3,274
+52% +$187K
PNFP icon
389
Pinnacle Financial Partners Inc
PNFP
$15.4B
$533K 0.01%
+6,192
New +$576K
TRMB icon
390
Trimble
TRMB
$14.2B
$523K 0.01%
+8,022
New +$557K
ALAB icon
391
Astera Labs
ALAB
$51.4B
$521K 0.01%
+4,758
New +$678K
CDW icon
392
CDW
CDW
$18.8B
$521K 0.01%
+4,308
New +$544K
LII icon
393
Lennox International
LII
$13.5B
$514K 0.01%
1,104
+64
+6% +$33K
GLW icon
394
Corning
GLW
$130B
$507K 0.01%
+3,731
New +$450K
COO icon
395
Cooper Companies
COO
$13.8B
$504K 0.01%
+7,048
New +$558K
ZS icon
396
Zscaler
ZS
$29.7B
$504K 0.01%
+3,592
New +$637K
NUE icon
397
Nucor
NUE
$56.7B
$503K 0.01%
+2,963
New +$516K
TSEM icon
398
Tower Semiconductor
TSEM
$24.4B
$495K 0.01%
+2,903
New +$390K
PDD icon
399
Pinduoduo
PDD
$122B
$484K 0.01%
4,735
-838
-15% -$88.1K
NLY icon
400
Annaly Capital Management
NLY
$17.4B
$480K 0.01%
22,056
-86,476
-80% -$1.97M
14 15
16
17 18

Similar funds

VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $2.16B AUM 21.9% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $2.16B AUM 28.67% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
PMFA
Plante Moran Financial Advisors Southfield, Michigan $2.15B AUM 22.82% 1-Year Est. Return
GG
Greenwood Gearhart Fayetteville, Arkansas $2.15B AUM 25.78% 1-Year Est. Return
NM
NWI Management New York $2.16B AUM 62.95% 1-Year Est. Return

Osmosis Investment Management UK's Q1 2026 Portfolio in Review

As of Q1 2026, Osmosis Investment Management UK held 499 positions worth $3.72B, down 6.1% from $3.97B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Osmosis Investment Management UK's Q1 2026 filing shows 131 new, 145 increased, 180 reduced and 43 closed positions. Its largest new stake was AstraZeneca: 199,294 shares worth $38.6M. The largest sale was Elevance Health, an estimated $24.3M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.

  • Osmosis Investment Management UK's largest Q1 2026 buy was AstraZeneca: 199,294 shares worth $38.6M.
  • Osmosis Investment Management UK added most to Southern Company in Q1 2026, an estimated $18.7M increase.
  • Osmosis Investment Management UK's biggest Q1 2026 reduction was Elevance Health, cutting an estimated $24.3M.
  • Osmosis Investment Management UK fully exited Fortinet in Q1 2026, selling an estimated $16.1M.
  • Osmosis Investment Management UK's ten largest holdings make up 34% of its $3.72B portfolio in Q1 2026.
  • Osmosis Investment Management UK opened 131 new positions and closed 43 in Q1 2026.
  • Osmosis Investment Management UK's portfolio value fell 6.1% quarter-over-quarter to $3.72B.

Based on Osmosis Investment Management UK's 13F filing for Q1 2026, filed 14 May 2026.